A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract

A Phase 2b, Randomized, Double-blind, Placebo-Controlled Multicenter Study Evaluating Antiviral Effects, Pharmacokinetics, Safety, and Tolerability of Presatovir in Hematopoietic Cell Transplant Recipients with Respiratory Syncytial Virus Infection of the Lower Respiratory Tract

Marty, Francisco M;Chemaly, Roy F;Mullane, Kathleen M;Lee, Dong-Gun;Hirsch, Hans H;Small, Catherine B;Bergeron, Anne;Shoham, Shmuel;Ljungman, Per;Waghmare, Alpana;Blanchard, Elodie;Kim, Yae-Jean;McKevitt, Matt;Porter, Danielle P;Jordan, Robert;Guo, Ying;German, Polina;Boeckh, Michael;Watkins, Timothy R;Chien, Jason W;Dadwal, Sanjeet S;
clinical infectious diseases 2020 Vol. 71 pp. 2787-2795
119
m2020clinicala

Abstract

Presatovir treatment was safe but did not improve viral or clinical outcomes in hematopoietic-cell transplant recipients with respiratory syncytial virus lower

Keywords

Citation

ID: 270003
Ref Key: m2020clinicala
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
270003
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet